Clinical Trial Update: IIT2025-03-YANG-LIFT-HCC [Phase 2]

View source ↗

Summary

Phase 2 IIT2025-03-YANG-LIFT-HCC trial for hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Ju Dong Yang | Conditions: Hepato Cellular Carcinoma | Phase 2 | Status: RECRUITING